1. D-109 Defining a potent new class of latency reversing agents devoid of toxicity and detrimental cell activation that enhance CTL/NK cell killing. (April 2018) Authors: Gramatica, Andrea; Schwarzer, Roland; Montano, Mauricio; Herzig, Eytan; Packard, Thomas; Greene, Warner C. Journal: Journal of acquired immune deficiency syndromes Issue: Volume 77(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗